Table 1. Basic Demographic Characteristics of Patients With Chronic HCV Infection a,b.
| Clinical characteristics | No. | value |
|---|---|---|
| Age, y, mean ± SD | 320 | 56.7 ± 12.8 |
| Male, n/No. (%) | 185/348 (53.2) | |
| Han population, n/No. (%) | 153/158 (96.8) | |
| HbsAg +, n/No. (%) | 14/117 (12.0) | |
| GGT-Ⅱ +, n/No. (%) | 23/125 (18.4) | |
| Smoking history, n/No. (%) | 47/151 (31.1) | |
| Drinking history, n/No. (%) | 39/153 (25.5) | |
| Blood transfusion history, n/No. (%) | 28/158 (17.7) | |
| Liver cirrhosis | 139/158 (88.0) | |
| HCV 1b, n/No. (%) | 132/176 (75.0) | |
| HCV-RNA > 400 000IU/mL, n/No. (%) | 180/292 (61.6) | |
| HCV-RNA, log IU/mL, median (IQR) | 292 | 5.97 (5.18-6.56) |
| ALT, U/L, median (IQR) | 158 | 55 (31.8-96.5) |
| AST, U/L, median (IQR) | 155 | 61 (42-97) |
| DBIL, umol/L, median (IQR) | 158 | 8.6 (5.4-14.0) |
| TBIL, umol/L, median (IQR) | 158 | 22.4 (13.7-36.1) |
| AFP, ng/mL, median (IQR) | 134 | 15.9 (8.3-49.0) |
| AFU, U/L, median (IQR) | 128 | 464.5 (36.3-637.3) |
| PT (s), mean ± SD | 158 | 15.9 ± 2.62 |
| PLT, ×109/L, mean ± SD | 158 | 98.5 ± 69.7 |
| ALP, U/L, mean ± SD | 156 | 91.0 ± 41.3 |
| ALB, g/L, mean ± SD | 157 | 33.6 ± 5.84 |
| CHO, mmol/L, mean ± SD | 115 | 3.32 ± 1.06 |
| TG, mmol/L, median (IQR) | 115 | 0.93 (0.70-1.39) |
a All data were obtained only from 158 inpatients except age, gender, HCV genotype and HCV virus load.
b Abbreviations: HbsAg, hepatitis B virus surface antigen; GGT-Ⅱ, γ-glutamyl transferase isoenzymesⅡ; ALT, alanine aminotransferase; AST, aspartate aminotransferase; DBIL, direct bilirubin; TBIL, total bilirubin; AFP, alpha fetoprotein; AFU, α-L-fucosidase; PT, prothrombin time; PLT, platelet; ALP, alkaline phosphatase; ALB, albumin; CHO, cholesterol; TG, triglyceride; IQR, Intra-quartile range (25th percentile–75th percentile); SD, standard deviation.